Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice

Immunology

Volumn 139, Issue 2, 2013, Pages 179-186

  Ellis, Jason S ^a   Wan, Xiaoxiao ^a   Braley Mullen, Helen ^a  

^a University of Missouri   (United States)

Author keywords

Autoimmunity; Diabetes; Regulatory T cell; Salivary gland; Thyroid

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SALIVARY GLAND; SPONTANEOUS AUTOIMMUNE THYROIDITIS; THYROID GLAND;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ARTHRITIS; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; IMMUNOGLOBULIN G; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED NOD; RATS; SALIVARY GLANDS; SJOGREN'S SYNDROME; T-LYMPHOCYTES, REGULATORY; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 84876789733     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12065     Document Type: Article

References (51)

1. Noorchashm H, Lieu YK, Noorchashm N et al. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 1999; 163:743-50.
2. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998; 161:3912-8.
3. Wong FS, Wen L, Tang M et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 2004; 53:2581-7.
4. Serreze DV, Chapman HD, Niens M et al. Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies. Diabetes 2011; 60:2914-21.
5. Braley-Mullen H, Yu S. Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol 2000; 165:7262-9.
6. + T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J Exp Med 2006; 203:349-58.
7. Yu S, Ellis JS, Dunn R, Kehry MR, Braley-Mullen H. Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adults. Int Immunol 2012; 24:233-42.
8. O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, Finnegan A. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 2005; 174:3781-8.
9. Svensson L, Jirholt J, Holmdahl R, Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998; 111:521-6.
10. Hayakawa I, Tedder TF, Zhuang Y. B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice. Immunology 2007; 122:73-9.
11. Pijpe J, Meijer JM, Bootsma H, van der Wal JE, Spijkervet FK, Kallenberg CG, Vissink A, Ihrler S. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome. Arthritis Rheum 2009; 60:3251-6.
12. Meijer JM, Pijpe J, Vissink A, Kallenberg CG, Bootsma H. Treatment of primary Sjögren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment. Ann Rheum Dis 2009; 68:284-5.
13. Youinou P, Devauchelle V, Hutin P, Le Berre R, Saraux A, Pers JO. A conspicuous role for B cells In Sjögren's syndrome. Clin Rev Allergy Immunol 2007; 32:231-7.
14. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189:1639-48.
15. Chan OT, Madaio MP, Shlomchik MJ. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999; 169:107-21.
16. Harvey BP, Gee RJ, Haberman AM, Shlomchik MJ, Mamula MJ. Antigen presentation and transfer between B cells and macrophages. Eur J Immunol 2007; 37:1739-51.
17. Yan J, Harvey BP, Gee RJ, Shlomchik MJ, Mamula MJ. B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J Immunol 2006; 177:4481-7.
18. Berek C, Kim HJ. B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis. Semin Immunol 1997; 9:261-8.
19. Yu S, Medling B, Yagita H, Braley-Mullen H. Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice. J Autoimmun 2001; 16:37-46.
20. Yu S, Sharp GC, Braley-Mullen H. Dual roles for IFN-γ, but not for IL-4, in spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol 2002; 169:3999-4007.
21. Leonardo SM, De Santis JL, Gehrand A, Malherbe LP, Gauld SB. Expansion of follicular helper T cells in the absence of Treg cells: implications for loss of B-cell anergy. Eur J Immunol 2012; 42:2597-607.
22. Leonardo SM, De Santis JL, Malherbe LP, Gauld SB. Cutting edge: in the absence of regulatory T cells, a unique Th cell population expands and leads to a loss of B cell anergy. J Immunol 2012; 188:5223-6.
23. + regulatory T cells. J Immunol 2003; 171:3348-52.
24. Zhong X, Gao W, Degauque N et al. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur J Immunol 2007; 37:2400-4.
25. Golovina TN, Mikheeva T, Suhoski MM et al. CD28 costimulation is essential for human T regulatory expansion and function. J Immunol 2008; 181:2855-68.
26. + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 2007; 178:3447-56.
27. Bour-Jordan H, Bluestone JA. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 2009; 229:41-66.
28. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009; 30:616-25.
29. Samy ET, Setiady YY, Ohno K, Pramoonjago P, Sharp C, Tung KS. The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function. Immunol Rev 2006; 212:170-84.
30. Hamel KM, Cao Y, Ashaye S, Wang Y, Dunn R, Kehry MR, Glant TT, Finnegan A. B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis. J Immunol 2011; 187:4900-6.
31. + T-cells control autoimmunity in the absence of B-cells. Diabetes 2009; 58:1568-77.
32. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:303-10.
33. Jain R, Tartar DM, Gregg RK et al. Innocuous IFN-γ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J Exp Med 2008; 205:207-18.
34. Braley-Mullen H, Sharp GC, Medling B, Tang H. Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Autoimmun 1999; 12:157-65.
35. Nguyen CQ, Yin H, Lee BH, Chiorini JA, Peck AB. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer. Lab Invest 2010; 91:54-62.
36. Nguyen CQ, Kim H, Cornelius JG, Peck AB. Development of Sjögren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3. J Immunol 2007; 179:2318-29.
37. Gregg RK, Bell JJ, Lee HH, Jain R, Schoenleber SJ, Divekar R, Zaghouani H. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance. J Immunol 2005; 174:662-70.
38. + regulatory T cells. Immunology 2007; 121:15-28.
39. Bernard NF, Ertug F, Margolese H. High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes 1992; 41:40-6.
40. Damotte D, Colomb E, Cailleau C, Brousse N, Charreire J, Carnaud C. Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis. Eur J Immunol 1997; 27:2854-62.
41. Martin AP, Marinkovic T, Canasto-Chibuque C et al. CCR7 deficiency in NOD mice leads to thyroiditis and primary hypothyroidism. J Immunol 2009; 183:3073-80.
42. Noorchashm H, Moore DJ, Noto LE et al. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol 2000; 165:4685-96.
43. Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009; 31:654-64.
44. Wan X, Guloglu FB, VanMorlan AM et al. Mechanisms underlying antigen-specific tolerance of stable and convertible Th17 cells during suppression of autoimmune diabetes. Diabetes 2012; 61:2054-65.
45. Schenke-Layland K, Xie J, Magnusson M et al. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy. Exp Eye Res 2011; 90:223-37.
46. Xiao W, Wu Y, Zhang J, Ye W, Xu GT. Selecting highly sensitive non-obese diabetic mice for improving the study of Sjögren's syndrome. Graefes Arch Clin Exp Ophthalmol 2009; 247:59-66.
47. Soyfoo MS, Steinfeld S, Delporte C. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome. Oral Dis 2007; 13:366-75.
48. Larche MJ. A short review of the pathogenesis of Sjögren's syndrome. Autoimmun Rev 2006; 5:132-5.
49. Cassell DJ, Schwartz RH. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J Exp Med 1994; 180:1829-40.
50. Kurt-Jones EA, Liano D, HayGlass KA, Benacerraf B, Sy MS, Abbas AK. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol 1988; 140:3773-8.
51. Janeway CA Jr, Ron J, Katz ME. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol 1987; 138:1051-5.